Our Team

Leann Kuhlmann-Qi (M.B.A.) has extensive experience managing the business aspects of early-stage biotechnology companies. Starting her career, she opened Kuhlmann Consulting where she completed various projects for clients including grant administration and creating a financial product to accompany a New York Times best seller product. At Cell Origins LLC, Leann Kuhlmann-Qi manages the business aspects of the company and leads the strategic development.

Jessica Newton-Northup (M.S.) has over two decades of experience working in the laboratory with phage display technology. She has carried out numerous phage display selections to identify and characterize cancer targeting ligands and the corresponding biomarkers. These efforts have resulted in about 30 published research articles and has contributed to many grants. Jessica Newton-Northup has also contributed to peptide science at an early-stage pharmaceutical company, where she was chiefly responsible for leading a team seeking to solve new challenges of peptide drug development. At Cell Origins LLC, Jessica Newton-Northup focuses her skills on phage display selection methods and development of new phage technologies to advance cell line verification.

Mette Soendergaard (Ph.D.) has over a decade of experience working with and leading research groups in phage display technology. She has pioneered the use of a two-tier phage display selection protocol as well as a method to select ligands for an ovarian cancer sub-population. Additionally, she has led successful projects to identify peptides that target various cancerous tissues and biomarkers resulting in publication of several research articles. At Cell Origins LLC, Mette Soendergaard is focusing on leading the innovation of novel phage display technologies to advance selection protocols, cell line verification, and biomarker isolation.